Study of Simtuzumab in HIV and/or Hepatitis C- Infected Adults With Liver Fibrosis

Clinical trial NCT01707472 · COMPLETED

Trial details

NCT number: NCT01707472
Sponsor: Gilead Sciences
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Liver Fibrosis Hepatitis C HIV HIV/HCV Co-infection

Start date: 2012-10-04
Primary completion: 2014-10-17
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.